RBOT Stock Overview
Develops and sells single-port surgical robot in the United States. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Vicarious Surgical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$12.92 |
52 Week High | US$21.43 |
52 Week Low | US$4.27 |
Beta | 1.34 |
1 Month Change | 12.45% |
3 Month Change | 136.63% |
1 Year Change | -5.43% |
3 Year Change | -95.93% |
5 Year Change | n/a |
Change since IPO | -95.58% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate
Nov 30Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Aug 16Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Mar 05Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Nov 24Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 18Vicarious Surgical: Cash Burn Adds To Downside Risk
May 26Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02
Feb 13Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03
Nov 07Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02
Aug 08Vectoring In On Vicarious Surgical Inc.
Jun 23Vicarious Surgical: Developing Minimally Invasive VR Surgical System
Nov 29Shareholder Returns
RBOT | US Medical Equipment | US Market | |
---|---|---|---|
7D | -9.3% | -1.2% | -2.7% |
1Y | -5.4% | 10.0% | 23.4% |
Return vs Industry: RBOT underperformed the US Medical Equipment industry which returned 10% over the past year.
Return vs Market: RBOT underperformed the US Market which returned 23.4% over the past year.
Price Volatility
RBOT volatility | |
---|---|
RBOT Average Weekly Movement | 19.7% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: RBOT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: RBOT's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 130 | Adam Sachs | www.vicarioussurgical.com |
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.
Vicarious Surgical Inc. Fundamentals Summary
RBOT fundamental statistics | |
---|---|
Market cap | US$70.90m |
Earnings (TTM) | -US$62.41m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.2x
P/E RatioIs RBOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RBOT income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$62.41m |
Earnings | -US$62.41m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -10.56 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0% |
How did RBOT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 02:07 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vicarious Surgical Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Gorman | BTIG |
Matthew Miksic | Credit Suisse |
Adam Maeder | Piper Sandler Companies |